Skip to main content
Clinical Trials/NCT03883893
NCT03883893
Withdrawn
Phase 2

Randomized Prospective Study Investigating the Analgesic Efficacy of Intravenous Acetaminophen in Reducing Post-Tonsillectomy Pain in Pediatric Patients

Overview

Phase
Phase 2
Intervention
Intravenous acetaminophen
Conditions
Tonsillectomy
Sponsor
Children's Hospital Medical Center, Cincinnati
Primary Endpoint
Post-operative pain scores
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

This study is a randomized prospective study to compare the post-operative analgesic efficacy of intravenous acetaminophen 15 mg/kg to an equal volume of 0.9% normal saline when all other analgesic interventions have been standardized for all patients enrolled.

Registry
clinicaltrials.gov
Start Date
December 2021
End Date
April 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The subject is age 3 to 10 years (inclusive)
  • The subject weighs more than 10.0 kg (inclusive of the tenth kilogram)
  • The subject is scheduled for the following: Elective tonsillectomy or tonsillectomy with adenoidectomy scheduled on an outpatient basis, with acceptable inclusion of patients also having PETs and/or EUA of ear
  • The subject is ASA patient classification I-II
  • The subject's legally authorized representative has given written informed consent to participate in the study and when appropriate, the subject has given assent or consent to participate.

Exclusion Criteria

  • Additional surgical procedures are being performed concurrently;
  • The subject is ASA classification \> II;
  • The subject has pre-existing allergy or known hypersensitivity to acetaminophen;
  • The subject receives midazolam as a premedication;
  • The subject has a history of chronic malnutrition;
  • The subject has any other condition, which in the opinion of the principal investigator, would not be suitable for participation in the study

Arms & Interventions

IV Tylenol

Participants will receive IV acetaminophen 15mg/kg in the OR.

Intervention: Intravenous acetaminophen

Normal Saline

Participants will receive 0.9% normal saline in the OR. The amount received will be equivalent of what would be given if they were receiving IV acetaminophen.

Intervention: Normal saline

Outcomes

Primary Outcomes

Post-operative pain scores

Time Frame: Every 5 minutes after awake in recovery room for 30 minutes

FLACC (Face, Legs, Activity, Cry, Consolability) behavior scale Each area measured is graded 0 - 2 and then totaled. Total score will range from 0 - 10. A total score of 0 - patient is relaxed and comfortable, 1 - 3 - patient is mildly uncomfortable, 4 - 6 - patient is in moderate pain, 7 - 10 - patient is having severe discomfort/pain

Secondary Outcomes

  • Quality of emergence from anesthesia(When first spontaneous eye movement occurs in recovery room)

Similar Trials